# STAVUDINE; LAMIVUDINE; NEVIRAPINE
> **NDA022177** · New Drug Application · Sponsor: STRIDES ACROLAB · Approved 2008-03-20
## Drug
- **FDA Application Number:** NDA022177
- **Application type:** New Drug Application
- **Brand name:** STAVUDINE; LAMIVUDINE; NEVIRAPINE
- **Generic name:** Stavudine
- **Active ingredients:** STAVUDINE; LAMIVUDINE; NEVIRAPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** STRIDES ACROLAB
- **First approval:** 2008-03-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022177)
---
*AI Analytics · CC0 1.0*